89 related articles for article (PubMed ID: 27125323)
1. New sonographic morphology score for the differentiation of malignant from benign ovarian tumors.
Shen ZY; He AQ; Xia GL; Wu MF; Li J; Ding YS
J Obstet Gynaecol Res; 2016 Aug; 42(8):1000-12. PubMed ID: 27125323
[TBL] [Abstract][Full Text] [Related]
2. Sonographic morphology scores (SMS) for differentiation between benign and malignant ovarian tumor.
Wanapirak C; Nimitwongsakul S; Tongsong T
J Med Assoc Thai; 2001 Jan; 84(1):30-5. PubMed ID: 11281497
[TBL] [Abstract][Full Text] [Related]
3. Combination of Sonographic Morphology Score and Tumor Markers for Detecting Postoperative Recurrent Pelvic Ovarian Carcinoma: Compared With MRI Assessment.
Shen ZY; Shen AJ; Yang SL; Wu MF
Ultrasound Q; 2019 Mar; 35(1):45-53. PubMed ID: 30672869
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the five sonographic morphology scoring systems for the diagnosis of malignant ovarian tumors.
Klangsin S; Suntharasaj T; Suwanrath C; Kor-Anantakul O; Prasartwanakit V
Gynecol Obstet Invest; 2013; 76(4):248-53. PubMed ID: 24192793
[TBL] [Abstract][Full Text] [Related]
5. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
6. Sonographic morphology scores (SMS) for differentiation between benign and malignant adnexal masses.
Wanapirak C; Srisupundit K; Tongsong T
Asian Pac J Cancer Prev; 2006; 7(3):407-10. PubMed ID: 17059332
[TBL] [Abstract][Full Text] [Related]
7. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
Czekierdowski A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
[TBL] [Abstract][Full Text] [Related]
8. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors].
Smoleń A; Stachowicz N; Czekierowski A; Kotarski J
Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic importance of the sonographic scoring system in differentiating between malignant and benign ovarian tumors].
Durdević S
Med Pregl; 2001; 54(3-4):161-5. PubMed ID: 11759208
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of sonographic morphology indexing and serum CA-125 for preoperative differentiation of malignant from benign ovarian tumors in patients after operation with ovarian tumors.
Jeoung HY; Choi HS; Lim YS; Lee MY; Kim SA; Han SJ; Ahn TG; Choi SJ
J Gynecol Oncol; 2008 Dec; 19(4):229-35. PubMed ID: 19471578
[TBL] [Abstract][Full Text] [Related]
11. Role of osteopontin in differential diagnosis of ovarian tumors.
Moszynski R; Szubert S; Szpurek D; Michalak S; Sajdak S
J Obstet Gynaecol Res; 2013 Nov; 39(11):1518-25. PubMed ID: 23875677
[TBL] [Abstract][Full Text] [Related]
12. Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter study.
Ferrazzi E; Zanetta G; Dordoni D; Berlanda N; Mezzopane R; Lissoni AA
Ultrasound Obstet Gynecol; 1997 Sep; 10(3):192-7. PubMed ID: 9339526
[TBL] [Abstract][Full Text] [Related]
13. A new sonomorphologic scoring-system (Mainz score) for the assessment of ovarian tumors using transvaginal ultrasonography. Part II: A comparison between the scoring-system and the assessment by an experienced sonographer in postmenopausal women.
Weber G; Merz E; Bahlmann F; Leber AM
Ultraschall Med; 1999 Feb; 20(1):2-8. PubMed ID: 10226339
[TBL] [Abstract][Full Text] [Related]
14. Comparing the Copenhagen Index (CPH-I) and Risk of Ovarian Malignancy Algorithm (ROMA): Two equivalent ways to differentiate malignant from benign ovarian tumors before surgery?
Yoshida A; Derchain SF; Pitta DR; Andrade LA; Sarian LO
Gynecol Oncol; 2016 Mar; 140(3):481-5. PubMed ID: 26825617
[TBL] [Abstract][Full Text] [Related]
15. Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components.
Testa AC; Timmerman D; Van Belle V; Fruscella E; Van Holsbeke C; Savelli L; Ferrazzi E; Leone FP; Marret H; Tranquart F; Exacoustos C; Nazzaro G; Bokor D; Magri F; Van Huffel S; Ferrandina G; Valentin L
Ultrasound Obstet Gynecol; 2009 Dec; 34(6):699-710. PubMed ID: 19924735
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ultrasound score, CA125, menopausal status, and risk of malignancy index in differentiating between benign and borderline or malignant ovarian tumors.
Leelahakorn S; Tangjitgamol S; Manusirivithaya S; Thongsuksai P; Jaroenchainon P; Jivangkul C
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S22-30. PubMed ID: 17718292
[TBL] [Abstract][Full Text] [Related]
17. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
[TBL] [Abstract][Full Text] [Related]
18. Does three-dimensional power Doppler ultrasound help in discrimination between benign and malignant ovarian masses?
Jokubkiene L; Sladkevicius P; Valentin L
Ultrasound Obstet Gynecol; 2007 Feb; 29(2):215-25. PubMed ID: 17201017
[TBL] [Abstract][Full Text] [Related]
19. A critical evaluation of transvaginal Doppler studies, transvaginal sonography, magnetic resonance imaging, and CA 125 in detecting ovarian cancer.
Hata K; Hata T; Manabe A; Sugimura K; Kitao M
Obstet Gynecol; 1992 Dec; 80(6):922-6. PubMed ID: 1448260
[TBL] [Abstract][Full Text] [Related]
20. Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging.
Weiner Z; Thaler I; Beck D; Rottem S; Deutsch M; Brandes JM
Obstet Gynecol; 1992 Feb; 79(2):159-62. PubMed ID: 1731278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
